MarketInOut Stock Screener Log In | Sign Up
 

Seaport Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Seaport Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,096.84 mln
Float13.80 mln
Earnings Date11/12/2026

Relative Strength

96 / 100
Top performer

Debt / Equity

0.01
Debt-free

ROE

-27.84
Deeply negative

ROA

-26.30
Deeply negative

Business Description

Seaport Therapeutics is a Boston-based startup focused on creating better treatments for mental health conditions like depression and anxiety. The company uses its own proprietary delivery technology to make drugs that can be taken orally while minimizing liver-related side effects that have historically limited similar treatments. Founded in 2024, Seaport is working to bring safer and more effective neuropsychiatric medicines to patients and the clinicians who treat them.

Key Fundamentals

EPS-5.81
ROE-27.84
ROIC-90.23
ROA-26.30
EBITDA, mln-87.33
EV / EBITDA-9.54
EV / EBIT-9.47

Quote Details

Last 20.61
Change -0.15 (-0.72%)
Open 20.72
Volume 164,564
Turnover 3,391,664
Average Volume 213,129

Financial Ratios

Leverage Ratio1.05
Current Ratio18.00
Price / Book2.61
Price / Tangible Book2.61
Debt / Equity0.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 15.59% 97 / 100   
1 Month -2.41% 49 / 100   
2 Months 0.29% 61 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog